120 related articles for article (PubMed ID: 1398887)
1. Phosphoramidon-sensitive effects of big endothelins in the perfused rabbit kidney.
Télémaque S; Lemaire D; Claing A; D'Orléans-Juste P
Hypertension; 1992 Oct; 20(4):518-23. PubMed ID: 1398887
[TBL] [Abstract][Full Text] [Related]
2. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney.
Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat.
Pollock DM; Divish BJ; Milicic I; Novosad EI; Burres NS; Opgenorth TJ
Eur J Pharmacol; 1993 Feb; 231(3):459-64. PubMed ID: 8449237
[TBL] [Abstract][Full Text] [Related]
4. Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs.
Gratton JP; Rae GA; Claing A; Télémaque S; D'Orléans-Juste P
Br J Pharmacol; 1995 Feb; 114(3):720-6. PubMed ID: 7735698
[TBL] [Abstract][Full Text] [Related]
5. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.
D'Orléans-Juste P; Télémaque S; Claing A
Br J Pharmacol; 1991 Oct; 104(2):440-4. PubMed ID: 1797310
[TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
[TBL] [Abstract][Full Text] [Related]
8. Analysis of responses to big endothelin in the hindquarters vascular bed of the cat.
Tamura DY; Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ
Can J Cardiol; 1992 Nov; 8(9):954-60. PubMed ID: 1486546
[TBL] [Abstract][Full Text] [Related]
9. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat.
Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
Life Sci; 1994; 55(16):1285-91. PubMed ID: 7934630
[TBL] [Abstract][Full Text] [Related]
10. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-independent pressor effect of big endothelin-1 and its inhibition by phosphoramidon in rat mesenteric artery.
Hisaki K; Matsumura Y; Nishiguchi S; Fujita K; Takaoka M; Morimoto S
Eur J Pharmacol; 1993 Sep; 241(1):75-81. PubMed ID: 8223929
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1.
Télémaque S; Gratton JP; Claing A; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S85-9. PubMed ID: 7510007
[TBL] [Abstract][Full Text] [Related]
13. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361
[TBL] [Abstract][Full Text] [Related]
14. Diuretic-natriuretic actions and pressor effects of big-endothelin (1-39) in phosphoramidon-treated rats.
Hoffman A; Haramati A; Dalal I; Shuranyi E; Winaver J
Proc Soc Exp Biol Med; 1994 Feb; 205(2):168-73. PubMed ID: 8108467
[TBL] [Abstract][Full Text] [Related]
15. The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery, but not in saphenous vein.
Auguet M; Delaflotte S; Chabrier PE; Braquet P
Eur J Pharmacol; 1992 Nov; 224(1):101-2. PubMed ID: 1451739
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
[TBL] [Abstract][Full Text] [Related]
17. Evidence for phosphoramidon-sensitive cleavage of big endothelin-1 involved in endothelin-stimulated hepatic glucose production.
Roden M; Prskavec M; Fürnsinn C; Schneider B; Waldhäusl W; Vierhapper H
Regul Pept; 1994 May; 51(3):207-13. PubMed ID: 7938704
[TBL] [Abstract][Full Text] [Related]
18. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
[TBL] [Abstract][Full Text] [Related]
19. Differences in potency of big endothelin-1-induced pressor action in rat isolated perfused mesenteric artery, hindquarter and lung.
Hisaki K; Matsumura Y; Fujita K; Maekawa H; Takaoka M; Morimoto S
Life Sci; 1994; 54(4):275-80. PubMed ID: 8289588
[TBL] [Abstract][Full Text] [Related]
20. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
